Table 1.
Relationship between NRP-1 protein expression and clinical pathological parameters
Number | Lower level of NRP-1 | Higher level of NRP-1 | P value | |
---|---|---|---|---|
Gender | 0.738 | |||
Male | 87 | 47 | 40 | |
Female | 54 | 25 | 29 | |
Age median (range):53.4 (27–82) | 0.345 | |||
<60 | 93 | 43 | 50 | |
≥60 | 48 | 29 | 19 | |
TNM stage | 0.019 | |||
Stage 0 | 5 | 4 | 1 | |
Stage I | 26 | 20 | 6 | |
Stage II | 38 | 23 | 15 | |
Stage III | 49 | 18 | 31 | |
Stage IV | 23 | 7 | 16 | |
WHO histologic classification | 0.046 | |||
Tubular | 67 | 38 | 29 | |
Papillary | 42 | 22 | 20 | |
Mucinous | 13 | 4 | 9 | |
Poorly cohesive | 11 | 3 | 8 | |
Uncommon histologic variants | 8 | 5 | 3 | |
Differentiation | 0.025 | |||
Well | 35 | 27 | 8 | |
Moderate | 74 | 36 | 38 | |
Poor | 32 | 9 | 23 |
Notes: NRP-1, Neuropilin-1. P value was estimated by Mann Whitney test